Skip to content

Clinical trials

Thrombocytopenia trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocytopenia Country / region: Australia Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20062
20092
20111
20122
20133
20143
20161
20201
20211
20221
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated4
Recruiting2
Withdrawn2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
Amgen2
CTI BioPharma2
Eisai Inc.2
GlaxoSmithKline2
Takeda2
Bristol-Myers Squibb1
Children's Oncology Group1
Hutchmed1
Kezar Life Sciences, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocytopenia21
Purpura, Thrombocytopenic, Idiopathic7
Anemia5
Hematologic Diseases5
Purpura4
Hemorrhagic Disorders3
Primary Myelofibrosis3
Purpura, Thrombocytopenic3
Autoimmune Diseases2
Blood Platelet Disorders2

Trials

Showing 51 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.